Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-05-16 00:00:00 ET · period of report 2023-05-12 · accession 0001209191-23-029870 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-16 | 2023-05-12 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $67.81 | +46.5K | 465.3K | +11% | +$3.15M |
| DM | 2023-05-16 | 2023-05-12 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | F - Tax | $93.93 | -40.0K | 466.4K | -8% | -$3.76M |
| DM | 2023-05-16 | 2023-05-12 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $0.00 | -46.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-12 | M | A | 7,370 | $67.81 | 472,713 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-12 | M | A | 39,130 | $67.81 | 465,343 | D | — | — | |
| 3 | Common | Common Stock | 2023-05-12 | F | D | 33,644 | $93.93 | 432,732 | D | — | — | |
| 4 | Common | Common Stock | 2023-05-12 | F | D | 6,337 | $93.93 | 466,376 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy Common Stock) | 2023-05-12 | M | D | 39,130 | $0.00 | 0 | D | $67.81 · 2013-11-15 to 2023-05-14 | 39,130 Common Stock | (F1) Reflects the number of options outstanding after the transactions from this specific stock option grant. |
| 6 | Derivative | Stock Option (Right to Buy Common Stock) | 2023-05-12 | M | D | 7,370 | $0.00 | 0 | D | $67.81 · 2013-11-15 to 2023-05-14 | 7,370 Common Stock | (F1) Reflects the number of options outstanding after the transactions from this specific stock option grant. |